{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:36:55Z","timestamp":1773787015320,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:27:25Z","timestamp":1660260445000},"page":"5513-5522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness analyses of monovalent mumps vaccination programs for Japanese children"],"prefix":"10.1016","volume":"40","author":[{"given":"Shu-ling","family":"Hoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xerxes","family":"Seposo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Shono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.08.004_b0005","unstructured":"WHO position paper on mumps virus vaccines. Weekly Epidemiological Record No 7. 16 February 2007."},{"issue":"20","key":"10.1016\/j.vaccine.2022.08.004_b0010","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1001\/jama.284.20.2643","article-title":"Mumps and rubella eliminated from Finland","volume":"284","author":"Peltola","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.08.004_b0015","doi-asserted-by":"crossref","unstructured":"Kidokoro M. [Future perspectives of mumps vaccine]. Uirusu. 2019;68(2):125\u201336 [In Japanese].","DOI":"10.2222\/jsv.68.125"},{"issue":"5","key":"10.1016\/j.vaccine.2022.08.004_b0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10156-013-0641-6","article-title":"Vaccine chronicle in Japan","volume":"19","author":"Nakayama","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2022.08.004_b0025","unstructured":"National Institute of Infectious Disease. Mumps 2016 September. IASR 2016;37:185\u20136. Available from: https:\/\/www.niid.go.jp\/niid\/ja\/mumps-m\/mumps-iasrtpc\/6822-440t.html [in Japanese] [accessed 20\/JUN\/2021]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0030","first-page":"233","article-title":"Age-specific incidence of aseptic meningitis following mumps vaccination from 2013\u20132016: estimation based on the number of reported adverse reactions to immunization in Japan","volume":"71","author":"Kumihashi","year":"2018","journal-title":"Jpn J Antibiotics"},{"key":"10.1016\/j.vaccine.2022.08.004_b0035","unstructured":"Petition calling for putting mumps monovalent vaccine into routine vaccination schedule. 2018, May, 14. The Expert Council on Promotion of Vaccination. Available from: https:\/\/www.mhlw.go.jp\/file\/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka\/0000213490.pdf [in Japanese] [accessed 20\/JUN\/2021]."},{"issue":"5","key":"10.1016\/j.vaccine.2022.08.004_b0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.11150\/kansenshogakuzasshi1970.81.555","article-title":"Cost-effectiveness analysis of routine mumps immunization in Japan","volume":"81","author":"Sugawara","year":"2007","journal-title":"Kansenshogaku Zasshi"},{"issue":"33","key":"10.1016\/j.vaccine.2022.08.004_b0045","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1016\/j.vaccine.2014.05.020","article-title":"Economic evaluation of vaccination programme of mumps vaccine to the birth cohort in Japan","volume":"32","author":"Hoshi","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.004_b0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7774\/cevr.2017.6.2.120","article-title":"Static model simulation for routine mumps vaccination in Japan: with a result of mumps-related complications in a Japanese community hospital","volume":"6","author":"Kitano","year":"2017","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2022.08.004_b0055","article-title":"Dynamic transmission model of routine mumps vaccination in Japan","volume":"147","author":"Kitano","year":"2018","journal-title":"Epidemiol Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2022.08.004_b0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2188\/jea.JE20200048","article-title":"Mumps-related disease burden in Japan: analysis of JMDC health insurance reimbursement data for 2005\u20132017","volume":"31","author":"Ohfuji","year":"2021","journal-title":"J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.004_b0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2188\/jea.JE20200233","article-title":"Incidence of mumps deafness in Japan, 2005\u20132017: analysis of Japanese insurance claims database","volume":"32","author":"Takagi","year":"2022","journal-title":"J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.08.004_b0070","unstructured":"Japan Pediatrics Vaccination Schedule March 24, 2021 Edition. Available from: http:\/\/www.jpeds.or.jp\/uploads\/files\/vaccine_schedule.pdf [in Japanese] [accessed 20\/JUN\/2021]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0075","unstructured":"Ministry of Health, Labour and Welfare. The 22th life tables. Tokyo: Health and Welfare Statistics Association; 2017 [in Japanese]."},{"issue":"Pt B","key":"10.1016\/j.vaccine.2022.08.004_b0080","article-title":"Epilepsy deaths: Learning from health service delivery and trying to reduce risk","volume":"103","author":"Morrish","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.vaccine.2022.08.004_b0085","unstructured":"Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. In: Hall E, Wodi AP, Hamborsky J, et al., editors. 14th ed. Washington, DC: Public Health Foundation; 2021. Available from: https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/mumps.html [in Japanese] [accessed 20\/JUN\/2021]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0090","doi-asserted-by":"crossref","unstructured":"Morimoto N, Masuda S, Aso S, Kashio A, Kanda Y, Nakazawa M, et al. Nationwide survey of hearing loss caused by mumps during 2015-2016 in Japan. Nippon Jibiinkoka Gakkai Kaiho (Tokyo) 2018;121:1173\u201380 [in Japanese].","DOI":"10.3950\/jibiinkoka.121.1173"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.004_b0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7883\/yoken.JJID.2018.276","article-title":"Effects of a public subsidy program for mumps vaccine on reducing the disease burden in Nagoya City, Japan","volume":"72","author":"Ozaki","year":"2019","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.004_b0100","first-page":"227","article-title":"Disease burden of the pediatric mumps based on the clinical analysis of the hospitalized patients during 2008\u20132014","volume":"29","author":"Kawaguchi","year":"2017","journal-title":"J Pediatric Infect Dis Immunol"},{"key":"10.1016\/j.vaccine.2022.08.004_b0105","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5692\/clinicalneurol.cn-000718","article-title":"Clinical, epidemiological and etiological studies of adult asptic meningitis: report of 13 cases with mumps meningitis","volume":"55","author":"Takeshima","year":"2015","journal-title":"Rinsho Shinkeigaku (Clin Neurol)"},{"key":"10.1016\/j.vaccine.2022.08.004_b0110","first-page":"182","article-title":"Investigation about serious cases caused by mumps virus and varicella-zoster virus","volume":"33","author":"Hosaka","year":"2012","journal-title":"J Jpn Pediatr Assoc"},{"issue":"8","key":"10.1016\/j.vaccine.2022.08.004_b0115","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1464-410X.2009.09148.x","article-title":"The increasing incidence of mumps orchitis: a comprehensive review","volume":"105","author":"Davis","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.vaccine.2022.08.004_b0120","unstructured":"Complications: mumps. NHS. Available from: https:\/\/www.nhs.uk\/conditions\/mumps\/complications\/ [accessed 2\/Oct\/2021]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0125","unstructured":"Guidelines for the management of acute pancreatitis: JPN guidelines 2015. Available from: http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jhbp.259\/full [accessed 20\/JUN\/2021]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0130","unstructured":"Ministry of Health, Labour and Welfare. Vital statistics of Japan; 2017. Health and Welfare Statistics Association, Tokyo. Available from: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/kakutei18\/index.html [in Japanese] [accessed 20\/JUN\/2021]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0135","doi-asserted-by":"crossref","unstructured":"Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2020;4(4):CD004407.","DOI":"10.1002\/14651858.CD004407.pub4"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.004_b0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1473-3099(20)30442-4","article-title":"Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis","volume":"21","author":"Schenk","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"44","key":"10.1016\/j.vaccine.2022.08.004_b0145","doi-asserted-by":"crossref","DOI":"10.3310\/hta13440","article-title":"The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model","volume":"13","author":"Bond","year":"2009","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.004_b0150","first-page":"1","article-title":"Bilateral cochlear implantation: a health technology assessment","volume":"18","year":"2018","journal-title":"Ont Health Technol Assess Ser"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.004_b0155","first-page":"208","article-title":"QOL in patients with unilateral hearing loss","volume":"91","author":"Iwasaki","year":"2019","journal-title":"Otolaryngol-Head Neck Surg (Tokyo)"},{"key":"10.1016\/j.vaccine.2022.08.004_b0160","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.vaccine.2022.08.004_b0165","unstructured":"Report of Vaccine Price Survey 2017. March 2018. Nihon Research Center Co., Ltd. Available from: http:\/\/www.toyama.med.or.jp\/wp\/wp-content\/uploads\/2018\/06\/osirase_iryoukikan_H29wakutinkakakutyousahoukoku.pdf [In Japanese] [accessed 20\/JUN\/2021]."},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.004_b0170","first-page":"279","article-title":"DRG\/PPS and DPC\/PDPS as prospective payment systems","volume":"55","author":"Ishii","year":"2012","journal-title":"Japan Med Assoc J"},{"key":"10.1016\/j.vaccine.2022.08.004_b0175","unstructured":"Igakutsushinsha. Simplified chart of DPC\/PDPS point Ver. 2020 Apr [DPC tensuu hayamihyou Ver. 2020 Apr]. Japan; 2020 [In Japanese]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0180","unstructured":"Bulletin of ACITA, August 2019. Association of Cochlear Implant Transmitted Audition Tokyo, Japan [in Japanese]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0185","first-page":"2206","article-title":"Burden of illness of bacterial meningitis and bacteremia caused by Streptococcus pneumonia in children","volume":"61","author":"Iwata","year":"2008","journal-title":"Jpn J Pediatr"},{"key":"10.1016\/j.vaccine.2022.08.004_b0190","unstructured":"Statistics Bureau, Ministry of Internal Affairs and Communications. Japan Statistical Yearbook 2021, Chapter 19, Table 6 Average monthly cash earnings per regular employee by industry. Available from: https:\/\/www.stat.go.jp\/english\/data\/nenkan\/70nenkan\/1431-19.html [In Japanese] [accessed 20\/JUN\/2021]."},{"key":"10.1016\/j.vaccine.2022.08.004_b0195","unstructured":"Research team on cost-effectiveness evaluation. Guideline for Preparing Cost-Effectiveness Evaluation to the Central Social Insurance Medical Council. Version 2.0 approved by CSIMC on 20th February, 2019 [in Japanese]."},{"issue":"Suppl_1","key":"10.1016\/j.vaccine.2022.08.004_b0200","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/378987","article-title":"An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States","volume":"189","author":"Hinman","year":"2004","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.004_b0205","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1542\/peds.2013-0698","article-title":"Economic evaluation of the routine childhood immunization program in the United States, 2009","volume":"133","author":"Zhou","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.08.004_b0210","unstructured":"Ontario Health (Quality). Implantable devices for single-sided deafness and conductive or mixed hearing loss: a health technology assessment. Ont Health Technol Assess Ser. 2020;20(1):1\u2013165."},{"issue":"9","key":"10.1016\/j.vaccine.2022.08.004_b0215","doi-asserted-by":"crossref","DOI":"10.3310\/hta18090","article-title":"Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey","volume":"18","author":"Longworth","year":"2014","journal-title":"Health Technol Assess"},{"issue":"9","key":"10.1016\/j.vaccine.2022.08.004_b0220","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1093\/gerona\/glab123","article-title":"Fall-related injuries mediate the relationship between self-reported hearing loss and mortality in middle-aged and older adults","volume":"76","author":"Xu","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:14:57Z","timestamp":1759403697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22009604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X22009604"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analyses of monovalent mumps vaccination programs for Japanese children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}